For purposes of computing the limitation under paragraph (1) for any taxable year, an individual who is an eligible individual during the last month of such taxable year shall be treated (i) as having been an eligible individual during each of the months in such taxable year, and (ii) as having been enrolled, during each of the months such individual is treated as an eligible individual solely by reason of clause (i), in the same high deductible health plan in which the individual was enrolled for the last month of such taxable year
In a clinical trial, patients taking Wegovy at the 2.4mg dose lost around 15 to 17% of their body weight over 68 weeks [1]
Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ
While lifestyle modifications like strength training, hydration, and high-protein nutrition are foundational, GLP-1 injections offer a powerful adjunct by helping to regulate metabolism and reduce appetite
Whether you need steady support or a sharp surge of energy, theres a patch for that
Survodutide , another GLP-1/glucagon dual agonist from Boehringer Ingelheim, is advancing through clinical trials
:format(webp))
